title: Progressive motor cortex functional reorganization following 6-hydroxydopamine lesioning in rats.
abstract: Many studies have attempted to correlate changes of motor cortex activity with progression of Parkinson's disease, although results have been controversial. In the present study we used intracortical microstimulation (ICMS) combined with behavioral testing in 6-hydroxydopamine hemilesioned rats to evaluate the impact of dopamine depletion on movement representations in primary motor cortex (M1) and motor behavior. ICMS allows for motor-effective stimulation of corticofugal neurons in motor areas so as to obtain topographic movements representations based on movement type, area size, and threshold currents. Rats received unilateral 6-hydroxydopamine in the nigrostriatal bundle, causing motor impairment. Changes in M1 were time dependent and bilateral, although stronger in the lesioned than the intact hemisphere. Representation size and threshold current were maximally impaired at 15 d, although inhibition was still detectable at 60-120 d after lesion. Proximal forelimb movements emerged at the expense of the distal ones. Movement lateralization was lost mainly at 30 d after lesion. Systemic L-3,4-dihydroxyphenylalanine partially attenuated motor impairment and cortical changes, particularly in the caudal forelimb area, and completely rescued distal forelimb movements. Local application of the GABA(A) antagonist bicuculline partially restored cortical changes, particularly in the rostral forelimb area. The local anesthetic lidocaine injected into the M1 of the intact hemisphere restored movement lateralization in the lesioned hemisphere. This study provides evidence for motor cortex remodeling after unilateral dopamine denervation, suggesting that cortical changes were associated with dopamine denervation, pathogenic intracortical GABA inhibition, and altered interhemispheric activity.
authors: Department of Experimental and Clinical Medicine, Section of Pharmacology, University of Ferrara, 44100 Ferrara, Italy. riccardo.viaro@unife.it
authors: Riccardo
authors: R
authors: Viaro
authors: Michele
authors: M
authors: Morari
authors: Gianfranco
authors: G
authors: Franchi
mesh_terms: D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D001640:Bicuculline / Q000494:pharmacology; D003714:Denervation; D015259:Dopamine Agents / Q000494:pharmacology; D004558:Electric Stimulation; D018756:GABA Antagonists / Q000494:pharmacology; D007150:Immunohistochemistry; D007980:Levodopa / Q000494:pharmacology; D008012:Lidocaine / Q000494:pharmacology; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009044:Motor Cortex / Q000502:physiology*; D016627:Oxidopamine / Q000633:toxicity*; D004856:Postural Balance / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D011963:Receptors, GABA-A / Q000187:drug effects; D026941:Sodium Channel Blockers / Q000494:pharmacology; D013565:Sympatholytics / Q000633:toxicity*; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D015259:Dopamine Agents; D018756:GABA Antagonists; D011963:Receptors, GABA-A; D026941:Sodium Channel Blockers; D013565:Sympatholytics; D007980:Levodopa; D016627:Oxidopamine; D008012:Lidocaine; D014446:Tyrosine 3-Monooxygenase; D001640:Bicuculline